New York Headache blog

by Dr. Alexander Mauskop
subscribe to our newsletter
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
We won’t share your data with third parties. Ever.
October 29, 2022
The 6th Annual International Headache Symposium in Israel
October 29, 2022
It was an honor to speak in Israel at the 6th Annual International Headache Symposium along with past presidents of the International Headache Society, Drs. Messoud Ashina and Alan Rapaport, the current IHS president, Cristina...
Read article
October 15, 2022
The 2nd edition of The End of Migraines, 150 Ways to Stop Your Pain was just published
October 15, 2022
The second updated and expanded edition of The End of Migraines, 150 Ways to Stop Your Pain is now available on Amazon.com. The book is available as an ebook, paperback and hardcover. I would recommend getting the Kindle...
Read article
October 5, 2022
How to treat nummular headache
October 5, 2022
Nummular (coin-shaped) headache is an uncommon condition. It is defined as intermittent or continuous pain in a small circumscribed area of the scalp with the following four characteristics: sharply-contoured...
Read article
September 26, 2022
Exercise prevents not only migraines but also shrinkage of the brain
September 26, 2022
Regular exercise has been proven to prevent migraine headaches in many studies. A Swedish study of 91 patients established that exercising for 40 minutes 3 times a week is as effective as relaxation training or taking a...
Read article
September 8, 2022
Daxxify, a new Botox competitor
September 8, 2022
No, Daxxify is not really a competitor in the treatment of chronic migraines or any other medical condition. Daxxify, a new botulinum toxin, was just approved by the FDA only for cosmetic use. Daxxify does stand out from five other...
Read article
August 19, 2022
Post-COVID headaches
August 19, 2022
Headache is a common symptom of any infectious illness, including COVID. A group of Spanish researchers analyzed six published studies of headaches in adult Spanish COVID patients. According to their review, headache...
Read article
August 8, 2022
If the effect of Botox does not last 3 months, taking a zinc supplement might help.
August 8, 2022
Dr. Brian Loftus, a Texas neurologist, alerted me to the possibility that the shortening of the effect of Botox can be reversed by taking a zinc supplement. Dr. Loftus shared an unpublished report by Houston physicians who...
Read article
July 30, 2022
Migraine patients stick with Botox longer than with injections of CGRP mAbs
July 30, 2022
Patients with chronic migraine who were started on Botox were significantly more likely to continue to be treated with Botox after one year than patients who were started on a CGRP monoclonal antibody (mAb). mAbs are given...
Read article
July 18, 2022
Rimegepant for trigeminal neuralgia: a case report
July 18, 2022
A case report presented at the annual meeting of the American Headache Society described a patient with trigeminal neuralgia (TN) whose pain responded well to rimegepant (Nurtec). Rimegepant is a drug approved...
Read article
July 11, 2022
Magnesium and migraines – an interview with Dr. Amelia Scott Barrett
July 11, 2022
Last week I spoke to Dr. Amelia Scott Barrett, a neurologist and headache specialist based in Denver. She shares my interest in combining medications with various non-drug therapies. In our first conversation, we discussed...
Read article
July 6, 2022
The 6th Annual International Headache Symposium in Israel
July 6, 2022
The 6th Annual International Headache Symposium in Israel will be held at Daniel Hotel, Herzliya (8 miles from Tel Aviv), on October 27, 2022. THe symposium is organized by the President of the Israeli Headache Association...
Read article
June 27, 2022
Intravenous magnesium prevents migraines in children
June 27, 2022
Regular intravenous infusions of magnesium prevented migraines in five children, according to a report presented at the annual meeting of the American Headache Society by A.J. Freed and S. Sahai-Srivastava. The children...
Read article
June 20, 2022
Acute migraine therapy in pregnancy – triptan is the safest choice.
June 20, 2022
Two out of three women stop having migraines during pregnancy, especially in the second and third trimester. The difficult question is how to treat migraines in the first trimester and in women whose migraines do not...
Read article
June 11, 2022
Cove presents its data on the efficacy of telemedicine in treating migraines
June 11, 2022
With tens of millions of Americans suffering from migraines, access to care is a major problem. Cove, a telemedicine startup, offers a practical and affordable solution. They deliver evidence-based therapies to patients in need...
Read article
June 10, 2022
Triptans are safe even in those with cardiovascular conditions – a new report
June 10, 2022
A paper presented at the annual meeting of the American Headache Society that is taking place this weekend examined the risk of major adverse cardiovascular events (MACE) in patients with preexisting cardiovascular...
Read article
June 4, 2022
Another study confirms vascular safety of triptans
June 4, 2022
Sumatriptan (Imitrex) and other triptans have been available without a prescription in all European countries for over a decade. A new study by Austrian researchers published in the current issue of Headache confirms the outstanding...
Read article
May 22, 2022
Primary stabbing headache
May 22, 2022
Primary stabbing headache is a rare disorder. Because it is rare, it is often misdiagnosed and not treated properly. This post was prompted by a patient with this condition I saw last week. She went undiagnosed for 45 years...
Read article
May 9, 2022
CGRP monoclonal antibodies in pregnancy
May 9, 2022
Not surprisingly, none of the new migraine drugs have been tested in pregnant women. No new drug for any indication is ever tested for its safety in human pregnancy. They are always tested in pregnant animals, which helps...
Read article
May 2, 2022
Rimegepant (Nurtec) is now approved in Europe
May 2, 2022
Rimegepant (Nurtec ODT) was just approved by the European Medicines Agency for marketing in 27 EU countries as well as Iceland, Liechtenstein, and Norway. It was approved for both the acute treatment of migraine...
Read article
April 21, 2022
Treating so-called medication overuse headache
April 21, 2022
If you are “overusing” acute migraine medications, preventive migraine treatments still work very well. This was the conclusion of a study that was just published in the journal of the American Academy of Neurology, Neurology...
Read article
April 14, 2022
What to do if Emgality, Aimovig, and Ajovy do not last a full month
April 14, 2022
Yesterday I saw a 48-year-old man who has been suffering from migraine headaches since his teens. He did not respond to a wide variety of drugs and non-drug therapies, but Emgality has been very effective. The only problem...
Read article
April 4, 2022
Headache after COVID vaccination
April 4, 2022
I recently saw a 32-year-old woman who never suffered from headaches until a year ago when she was given an injection of a COVID vaccine (J&J). Her headache started the day after vaccination and it has persisted unabated...
Read article
March 28, 2022
Chiropractic for migraine
March 28, 2022
A patient recently asked me about trying chiropractic treatment for her migraines. This is a chapter on chiropractic from my last book, The End of Migraines: 150 Ways to Stop Your Pain. Chiropractors can also relieve...
Read article
March 17, 2022
Attend RetreatMigraine, online or in person
March 17, 2022
RetreatMigraine 2022: April 1-3 at Hilton Charlotte University PlaceRetreatMigraine is a conference specially designed by and for adults living with migraine disease. The multi-day event brings together patients, care partners and...
Read article
March 10, 2022
Julie Mauskop at Shrine.nyc
March 10, 2022
See Julie’s solo show at Shrine.nyc, 179 East Broadway, New York, NY...
Read article
March 5, 2022
Relief for droopy eyelids caused by Botox
March 5, 2022
Botox is one of the most effective and safest treatments for frequent and chronic migraines. One of the potential side effects of Botox is droopy eyelids. When injections are done correctly this happens in a very small percentage...
Read article
February 24, 2022
Migraine World Summit is on again and it offers a wealth of information
February 24, 2022
I am happy to announce that you can attend the Migraine World Summit free of charge. It is back on March 16-24, 2022 for its 7th annual virtual event. As one of the former presenters, I can tell you that you may greatly benefit...
Read article
February 17, 2022
Combining peripheral electrical stimulation with relaxation training to treat migraine headaches
February 17, 2022
Nerivio, an electrical stimulation device was cleared by the FDA to treat acute migraine attacks in adults almost three years ago. It was recently also cleared to treat migraines in adolescents. A new study sponsored by Theranica...
Read article
February 5, 2022
Internet-delivered cognitive and behavioral interventions help chronic pain
February 5, 2022
My previous post described a study that found no difference in efficacy among different types of psychosocial interventions for the treatment of chronic back pain. A recent 2020 Cochrane review concluded that there is strong...
Read article
January 30, 2022
What is best – cognitive therapy, mindfulness-based stress reduction, or behavioral therapy?
January 30, 2022
Patients with chronic pain, including those with migraines, have been shown to benefit from psychological interventions. There is a wide variety of such treatments – biofeedback, meditation, acceptance-commitment...
Read article